ABCSG 26/SOLE Summary

Phase-III-trial evaluating the role of continuous letrozole vs. intermittent letrozole following 4 to 6 years of prior adjuvant endocrine therapy for postmenopausal women with hormone-receptor-positive, node-positive early-stage breast cancer.

Start: 2011
Coordinating investigator: Marth, Christian; Innsbruck
Sample size:
Design:
(Click to enlarge)
ABCSG-26 Design